BeiGene, Ltd. (BGNE) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 1000 transactions totaling $1.9B, demonstrating a bearish sentiment with -$1.8B in net insider flow. The most recent transaction on Sep 19, 2024 involved a sale of 4,500 shares valued at $900.6K.
No significant insider buying has been recorded for BGNE in the recent period.
No significant insider selling has been recorded for BGNE in the recent period.
Based on recent SEC filings, insider sentiment for BGNE is bearish with an Insider Alignment Score of 3/100 and a net flow of -$1.8B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at BeiGene, Ltd. (BGNE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading BGNE stock, having executed 1000 transactions in the past 90 days. The most active insider is Inc Amgen (Executive), who has made 12 transactions totaling $618.2M.
Get notified when executives and directors at BGNE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 19, 2024 | Wu Xiaobin | Executive | Sale | 4,500 | $200.14 | $900.6K | Large10b5-1 |
| Sep 17, 2024 | Wu Xiaobin | Executive | Sale | 500 | $200.00 | $100.0K | 10b5-1 |
| Sep 3, 2024 | B. Ball Titus | Executive | Sale | 137 | $189.94 | $26.0K | |
| Sep 3, 2024 | Wu Xiaobin | Executive | Sale | 700 | $191.20 | $133.8K | 10b5-1 |
| Sep 3, 2024 | Wu Xiaobin | Executive | Sale | 2,275 | $190.29 | $432.9K | 10b5-1 |
| Sep 3, 2024 | Wu Xiaobin | Executive | Sale | 275 | $188.97 | $52.0K | 10b5-1 |
| Sep 3, 2024 | Wu Xiaobin | Executive | Sale | 274 | $192.04 | $52.6K | 10b5-1 |
| Sep 3, 2024 | Wu Xiaobin | Executive | Sale | 2,032 | $188.16 | $382.3K | 10b5-1 |
| Aug 12, 2024 | Wang Xiaodong | Executive | Gift | 301,457 | $N/A | $0 | |
| Aug 9, 2024 | Rosenberg Aaron | Executive | Award | 118,547 | $N/A | $0 | |
| Jul 30, 2024 | Henry Lee Chan | Executive | Sale | 834 | $160.57 | $133.9K | |
| Jul 1, 2024 | Aijun Wang Julia | Executive | Sale | 472 | $143.90 | $67.9K | |
| Jun 24, 2024 | Oyler John | Executive | Sale | 400 | $160.12 | $64.0K | |
| Jun 24, 2024 | Oyler John | Executive | Sale | 2,389 | $159.49 | $381.0K | |
| Jun 24, 2024 | Wu Xiaobin | Executive | Sale | 23 | $161.27 | $3.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 851 | $1.8B | 68.4% |
Award(A) | 84 | $775.7M | 29.3% |
Purchase(P) | 1 | $50.0M | 1.9% |
Exercise(M) | 37 | $11.8M | 0.4% |
Gift(G) | 24 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Insider selling pressure at BeiGene, Ltd. has increased, with 28 insiders executing 1000 transactions across all time. Total sales of $1.8B significantly outpace purchases of $50.0M, resulting in a net outflow of $1.8B. This selling activity appears largely discretionary, which may warrant closer attention from investors.